Delivery Order HHSF223201510043I-75F40120F19004

Award Date 8/11/20
Potential Completion Date 9/29/21
Potential Value $960K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian government agency, to Label Insight, Inc., a for-profit organization. The contract, which does not have a set-aside designation, is for an "LABEL INSIGHT ENHANCED LICENSE" with a ceiling value of $338,080.32. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is September 29, 2020. This contract award does not appear to be...
<p>This is a federal delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Label Insight, Inc. The contract has a ceiling value of $3,779,241.39 and is a Firm Fixed Price type contract. The contract was awarded on September 30, 2015 and has an ultimate completion date of September 29, 2020. The place of performance is Rockville, MD. There is no set-aside designation mentioned for this award.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $4.8 million firm fixed price delivery order to Dun &amp; Bradstreet Inc., doing business as D&amp;B, for core services. The one-year contract will provide products and services to support HHS/FDA programs from D&amp;B's offices in Herndon, Virginia. As one of the largest federal civilian agencies, HHS/FDA relies on data and analytical tools from major database and research firms under the Solutions for...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $66,145 firm fixed price delivery order to Data Federal Corporation under the agency's Multiple Award Schedule contract vehicle. The order is associated with the FDA's Shelf Life Extension Program and provides for electronic records storage and document management services to support the agency's efforts to extend expiration dates of stockpiled strategic national stockpile pharmaceuticals and medical...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $40,143 purchase order contract to Proquest LLC for access to its legislative and regulatory insight collection for the years 2023 through 2024. Under the firm fixed price contract, Proquest will provide its database of materials tracking laws, regulations, and policies pertinent to HHS FDA programs and operations. No subcontractors or set aside designations were specified. The collection will support...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a definitive, firm-fixed-price contract to Life Science Intelligence Inc., a for-profit subchapter S corporation, for the provision of Market Share Reports and Database Tracking services. The contract, which does not have a set-aside designation, was awarded on September 8, 2017, with a potential value of $386,310.00 and a completion date of September 14, 2022. The place of performance is Huntington...
The Food and Drug Administration (FDA) awarded a $5,613,225.00 firm-fixed price delivery order to Nielsen Consumer LLC (doing business as Nielseniq) to provide access to a food and cosmetic product and packaging database. This order was issued against a larger $6 million single-award Indefinite Delivery Contract between the FDA and Nielseniq that runs through September 2026. The delivery order will support up to 200 users and provide the FDA with detailed data and insights on processed foods and...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Source Healthcare Analytics LLC, a global provider of outsourced development services to the pharmaceutical and medical device industries. The $140,032 contract is for access to prescription and non-retail sales data by geography, to support the FDA's monitoring of drug safety and effectiveness during the national health emergency. This award is associated with a larger $45...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $200,000.00 firm-fixed price purchase order contract to Datasembly Inc., a self-certified small disadvantaged business, for monitoring the status of the infant formula supply. The contract involves integrating and speeding the analysis of complex and varied data sources to help track the impact of efforts to increase product availability. The contract does not have a set-aside designation and is...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) to Dun &amp; Bradstreet Inc., doing business as Dun &amp; Bradstreet Receivable Management Services. The $653,981.14 contract is for the provision of database subscriptions, analytical services, and licensing to support the regulatory, compliance, and enforcement programs of the Food and Drug Administration (FDA), a component of HHS. This contract is issued under a $60 million...
  • HHSF223201510043I
    Indefinite Delivery Contract
  • HHSF223201510043I-75F40120F19004
    Delivery Order

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $959,700 firm fixed price delivery order contract to Label Insight, Inc. for food and cosmetic database support and services. The one-year contract, with a period of performance from August 11, 2020 to September 29, 2021, will provide Label Insight's database solutions to support HHS FDA programs in Silver Spring, Maryland. No subcontractors or set aside designations were identified. This order for database services is consistent with HHS FDA's regulatory responsibilities to ensure the safety of food, drugs, medical devices, and cosmetics in the United States.

Generated 12/25/23, 1:19 AM